End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51,300 KRW | -1.72% | -0.77% | -28.75% |
May. 03 | SK Bioscience's Attributable Loss Narrows in Q1 | MT |
Mar. 28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
Sales 2024 * | 242B 176M | Sales 2025 * | 325B 236M | Capitalization | 3,941B 2.86B |
---|---|---|---|---|---|
Net income 2024 * | -37B -26.86M | Net income 2025 * | -16B -11.62M | EV / Sales 2024 * | 12.8 x |
Net cash position 2024 * | 846B 614M | Net cash position 2025 * | 663B 482M | EV / Sales 2025 * | 10.1 x |
P/E ratio 2024 * |
-105
x | P/E ratio 2025 * |
-245
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 31.48% |
1 day | -1.72% | ||
1 week | -0.77% | ||
Current month | -0.77% | ||
1 month | -14.36% | ||
3 months | -16.99% | ||
6 months | -26.40% | ||
Current year | -28.75% |
Managers | Title | Age | Since |
---|---|---|---|
Jae-Yong An
CEO | Chief Executive Officer | 56 | - |
Yong-Sung Choi
DFI | Director of Finance/CFO | 51 | - |
Sally Choe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Choi
BRD | Director/Board Member | 60 | - |
Chang-Jin Moon
BRD | Director/Board Member | 71 | - |
Jae-Yong An
CEO | Chief Executive Officer | 56 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.57% | 2 M€ | -14.14% | ||
0.78% | 15 M€ | -3.81% | ||
0.04% | 15 M€ | +15.37% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 51,300 | -1.72% | 126,214 |
24-06-10 | 52,200 | -2.43% | 70,147 |
24-06-07 | 53,500 | +1.33% | 78,065 |
24-06-05 | 52,800 | +2.13% | 100,465 |
24-06-04 | 51,700 | 0.00% | 98,696 |
End-of-day quote Korea S.E., June 10, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.75% | 2.92B | |
-1.51% | 92.26B | |
-2.63% | 38.11B | |
-12.76% | 32.9B | |
+66.54% | 26.51B | |
-13.02% | 15.75B | |
-5.27% | 13.36B | |
-10.50% | 11.65B | |
-49.11% | 10.12B | |
+187.82% | 9.78B |
- Stock Market
- Equities
- A302440 Stock